Zebrafish embryos are well suited as a model system to perform chemical biology experiments effectively in educational settings. We studied the effect of caffeine on heart rate (HR) and other phenotypes of zebrafish embryos using visual microscopy and simple imaging. Acute treatment with millimolar concentrations of caffeine in embryo medium caused a dose-dependent decrease in HR in 2–3-day-old zebrafish embryos, ultimately resulting in complete HR cessation. A characteristic pattern of decrease in HR was observed, with an initial acute drop in HR and a period of stabilization followed by complete cessation. The effects of caffeine were not reversed by cotreatment with ruthenium red and adenosine, agents known to be antagonistic to caffeine, or by changes in calcium concentration in embryo medium. Apparent cardiac arrhythmia and a typical kinking effect in the trunk/tail region were also observed because of caffeine treatment. Our results, taken together with previous reports, raise the possibility that caffeine exerts its effects on embryonic HR of zebrafish by inhibition of ether-a-go-go potassium channels. However, further experimentation is required to dissect the molecular basis of caffeine action. We demonstrate that such experiments can be used to explore the effect of small molecules, such as caffeine, on cardiovascular phenotypes and to encourage experimental design in chemical biology.
Get full access to this article
View all access options for this article.
References
1.
ChouT. Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West J Med, 1992; 157:544–553.
2.
RobertsonD, FrolichJC, CarrRK, WatsonJT, HollifieldJW, ShandDGet al.Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med, 1978; 298:181–186.
3.
BattigK, BuzziR, MartinJR, FeierabendJM. The effects of caffeine on physiological functions and mental performance. Experientia, 1984; 40:1218–1223.
4.
MazzarelliM, JasparN, ZinWA, ArandaJV, Milic-EmiliJ. Dose effect of caffeine on control of breathing and respiratory response to CO2 in cats. J Appl Physiol, 1986; 60:52–59.
5.
GlatzelH, HackenbergK. [Effects of caffeine containing and decaffeinated coffee on the digestive functions. X-ray studies of the secretion and peristalsis of stomach, intestines and gallbladder]Med Klin, 1967; 62:625–628.
6.
RauhR, BurkertM, SiepmannM, Mueck-WeymannM. Acute effects of caffeine on heart rate variability in habitual caffeine consumers. Clin Physiol Funct Imaging, 2006; 26:163–166.
7.
KerriganS, LindseyT. Fatal caffeine overdose: two case reports. Forensic Sci Int, 2005; 153:67–69.
8.
SmithDL, TongJE, LeighG. Combined effects of tobacco and caffeine on the components of choice reaction-time heart rate, and hand steadiness. Percept Mot Skills, 1977; 45:635–639.
9.
GreenPJ, SulsJ. The effects of caffeine on ambulatory blood pressure, heart rate, and mood in coffee drinkers. J Behav Med, 1996; 19:111–128.
10.
KennedyMD, GallowayAV, DickauLJ, HudsonMK. The cumulative effect of coffee and a mental stress task on heart rate, blood pressure, and mental alertness is similar in caffeine-naive and caffeine-habituated females. Nutr Res, 2008; 28:609–614.
11.
BichlerA, SwensonA, HarrisMA. A combination of caffeine and taurine has no effect on short term memory but induces changes in heart rate and mean arterial blood pressure. Amino Acids, 2006; 31:471–476.
12.
McClaranSR, WetterTJ. Low doses of caffeine reduce heart rate during submaximal cycle ergometry. J Int Soc Sports Nutr, 2007; 4:11.
ChoiOH, ShamimMT, PadgettWL, DalyJW. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci, 1988; 43:387–398.
15.
MillerDJ, ThieleczekR. Calcium release by caffeine and other methylxanthines in skinned skeletal muscle fibres [proceedings]J Physiol, 1977; 273:67P–68P.
16.
YangJN, ChenJF, FredholmBB. Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol, 2009; 296:H1141–H1149.
YuL, CoelhoJE, ZhangX, FuY, TillmanA, KaraozUet al.Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling. Physiol Genomics, 2009; 37:199–210.
19.
HolderN, XuQ. The zebrafish: an overview of its early development. Methods Mol Biol, 2008; 461:483–491.
20.
SkromneI, PrinceVE. Current perspectives in zebrafish reverse genetics: moving forward. Dev Dyn, 2008; 237:861–882.
21.
LamSH, MathavanS, TongY, LiH, KaruturiRK, WuYet al.Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology. PLoS Genet, 2008; 4:e1000121.
22.
BrittijnSA, DuivesteijnSJ, BelmamouneM, BertensLF, BitterW, de BruijnJDet al.Zebrafish development and regeneration: new tools for biomedical research. Int J Dev Biol, 2009; 53:835–850.
23.
LohrJL, YostHJ. Vertebrate model systems in the study of early heart development: Xenopus and zebrafish. Am J Med Genet, 2000; 97:248–257.
24.
CrosierPS, Kalev-ZylinskaML, HallCJ, FloresMV, HorsfieldJA, CrosierKE. Pathways in blood and vessel development revealed through zebrafish genetics. Int J Dev Biol, 2002; 46:493–502.
25.
SchwerteT. Cardio-respiratory control during early development in the model animal zebrafish. Acta Histochem, 2009; 111:230–243.
26.
NemtsasP, WettwerE, ChristT, WeidingerG, RavensU. Adult zebrafish heart as a model for human heart? An electrophysiological study. J Mol Cell Cardiol, 2009; 48:161–171.
27.
BakerK, WarrenKS, YellenG, FishmanMC. Defective “pacemaker” current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci USA, 1997; 94:4554–4559.
28.
BagattoB, BurggrenW. A three-dimensional functional assessment of heart and vessel development in the larva of the zebrafish (Danio rerio)Physiol Biochem Zool, 2006; 79:194–201.
29.
BurnsCG, MilanDJ, GrandeEJ, RottbauerW, MacRaeCA, FishmanMC. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol, 2005; 1:263–264.
30.
KoppR, SchwerteT, PelsterB. Cardiac performance in the zebrafish breakdance mutant. J Exp Biol, 2005; 208,Pt 11:2123–2134.
31.
ChanPK, LinCC, ChengSH. Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos. BMC Biotechnol, 2009; 9:11.
32.
MilanDJ, PetersonTA, RuskinJN, PetersonRT, MacRaeCA. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation, 2003; 107:1355–1358.
33.
SteeleSL, LoKH, LiVW, ChengSH, EkkerM, PerrySF. Loss of M2 muscarinic receptor function inhibits development of hypoxic bradycardia and alters cardiac beta-adrenergic sensitivity in larval zebrafish (Danio rerio)Am J Physiol Regul Integr Comp Physiol, 2009; 297:R412–R420.
ChenYH, HuangYH, WenCC, WangYH, ChenWL, ChenLCet al.Movement disorder and neuromuscular change in zebrafish embryos after exposure to caffeine. Neurotoxicol Teratol, 2008; 30:440–447.
36.
EganRJ, BergnerCL, HartPC, CachatJM, CanavelloPR, EleganteMFet al.Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res, 2009; 205:38–44.
37.
KoulenP, JanowitzT, JohenningFW, EhrlichBE. Characterization of the calcium-release channel/ryanodine receptor from zebrafish skeletal muscle. J Membr Biol, 2001; 183:155–163.
38.
XieY, OttoliaM, JohnSA, ChenJN, PhilipsonKD. Conformational changes of a Ca2+-binding domain of the Na+/Ca2+ exchanger monitored by FRET in transgenic zebrafish heart. Am J Physiol Cell Physiol, 2008; 295:C388–C393.
39.
BoehmlerW, PetkoJ, WollM, FreyC, ThisseB, ThisseCet al.Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patterns, 2009; 9:144–151.
40.
SelderslaghsIW, Van RompayAR, De CoenW, WittersHE. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol, 2009; 28:308–320.
41.
HagedornM, KleinhansFW, ArtemovD, PilatusU. Characterization of a major permeability barrier in the zebrafish embryo. Biol Reprod, 1998; 59:1240–1250.
42.
BradfieldJY, WestJR, MaierSE. Uptake and elimination of ethanol by young zebrafish embryos. Neurotoxicol Teratol, 2006; 28:629–633.
43.
McGarrySJ, WilliamsAJ. Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel. J Membr Biol, 1994; 137:169–177.
44.
FieldsM. The art and science of zebrafish in the classroom—an interview with Melanie Fields, interviewed by Lara D. Hutson. Zebrafish, 2009; 6:121–126.
45.
WesterfieldM. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio), 4th. Eugene, OR: University of Oregon Press, 2000.
46.
HasselbachW, MigalaA. Modulation by ryanodine of active calcium loading and caffeine induced calcium release of heavy sarcoplasmic reticulum vesicles. Z Naturforsch [C], 1992; 47:429–439.
47.
OpieLH. Calcium ions, drug action and the heart—with special reference to calcium antagonist drugs. Pharmacol Ther, 1984; 25:271–295.
48.
MaltsevVA, VinogradovaTM, BogdanovKY, LakattaEG, SternMD. Diastolic calcium release controls the beating rate of rabbit sinoatrial node cells: numerical modeling of the coupling process. Biophys J, 2004; 86:2596–2605.
49.
EgyhaziE, HolstM. Adenosine selectively inhibits labeling of chromosomal RNA, especially hnRNA, probably by acting at or near the site of chain initiation. J Cell Biol, 1981; 89:1–8.
50.
BoursMJ, BosHJ, MeddingsJB, BrummerRJ, van den BrandtPA, DagneliePC. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. BMC Gastroenterol, 2007; 7:23.
51.
HisayamaT, TakayanagiI. Ryanodine: its possible mechanism of action in the caffeine-sensitive calcium store of smooth muscle. Pflugers Arch, 1988; 412:376–381.
52.
MaJ. Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle. J Gen Physiol, 1993; 102:1031–1056.
53.
BakuridzeK, DuzenliS, GepdiremenA. The role of ruthenium red as a partial agonist in caffeine-induced neurotoxicity in cerebellar granular cell culture of rats. Int J Neurosci, 2005; 115:13–21.
54.
KiehnJ, LacerdaAE, WibleB, BrownAM. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation, 1996; 94:2572–2579.
55.
RajamaniS, EckhardtLL, ValdiviaCR, KlemensCA, GillmanBM, AndersonCLet al.Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol, 2006; 149:481–489.
56.
HillAP, SundeM, CampbellTJ, VandenbergJI. Mechanism of block of the hERG K+ channel by the scorpion toxin CnErg1. Biophys J, 2007; 92:3915–3929.
57.
WangMH, TsengCD, BairSY. Q-T interval prolongation and pleomorphic ventricular tachyarrhythmia (‘Torsade de pointes’) in organophosphate poisoning: report of a case. Hum Exp Toxicol, 1998; 17:587–590.
58.
CockerillSL, MitchesonJS. Direct block of human ether-a-go-go-related gene potassium channels by caffeine. J Pharmacol Exp Ther, 2006; 316:860–868.
59.
LangheinrichU, VacunG, WagnerT. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol, 2003; 193:370–382.
60.
MittelstadtSW, HemenwayCL, CraigMP, HoveJR. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG. J Pharmacol Toxicol Methods, 2008; 57:100–105.
61.
SutherlandDJ, McPhersonDD, RentonKW, SpencerCA, MontagueTJ. The effect of caffeine on cardiac rate, rhythm, and ventricular repolarization. Analysis of 18 normal subjects and 18 patients with primary ventricular dysrhythmia. Chest, 1985; 87:319–324.
62.
HutsonLD, LiangJO. Making an impact: zebrafish in education. Zebrafish, 2009; 6:119–120.
63.
McKeownKA, DownesGB, HutsonLD. Modular laboratory exercises to analyze the development of zebrafish motor behavior. Zebrafish, 2009; 6:179–185.
64.
Grossarth-MaticekR, EysenckHJ. Coca-Cola, cancers, and coronaries: personality and stress as mediating factors. Psychol Rep, 1991; 68,3, Pt 2:1083–1087.
65.
LuebbeAM, BellDJ. Mountain Dew or mountain don't?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students. J Sch Health, 2009; 79:380–387.
66.
ChouKH, BellLN. Caffeine content of prepackaged national-brand and private-label carbonated beverages. J Food Sci, 2007; 72:C337–C342.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
